Recent chatter on X about Vivani Medical (VANI) has been sparked by a significant insider purchase, with reports of a director acquiring over 1.7 million shares worth nearly $2 million. This move has fueled speculation among users about the potential for a turnaround in the company’s stock performance. Many are pointing to high-volume buying as a positive signal, stirring interest in the biopharmaceutical firm's future.
The discussion also touches on Vivani’s innovative NanoPortal™ technology and its potential in chronic disease treatment, with some expressing optimism about upcoming clinical milestones. However, there are cautious voices questioning whether such insider activity guarantees long-term growth. This mix of excitement and skepticism keeps the conversation dynamic and engaging.
Note: This discussion summary was generated from an AI condensation of post data.
Vivani Medical Insider Trading Activity
Vivani Medical insiders have traded $VANI stock on the open market 10 times in the past 6 months. Of those trades, 10 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $VANI stock by insiders over the last 6 months:
- GREGG WILLIAMS has made 10 purchases buying 3,821,882 shares for an estimated $4,399,155 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Vivani Medical Hedge Fund Activity
We have seen 16 institutional investors add shares of Vivani Medical stock to their portfolio, and 9 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SABBY MANAGEMENT, LLC removed 757,782 shares (-89.0%) from their portfolio in Q2 2025, for an estimated $977,538
- VANGUARD GROUP INC added 465,188 shares (+48.1%) to their portfolio in Q2 2025, for an estimated $600,092
- TANAGER WEALTH MANAGEMENT LLP removed 202,654 shares (-16.6%) from their portfolio in Q2 2025, for an estimated $261,423
- CONNECTIVE CAPITAL MANAGEMENT, LLC removed 162,098 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $209,106
- WEALTHEDGE INVESTMENT ADVISORS, LLC removed 125,033 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $161,292
- PANAGORA ASSET MANAGEMENT INC added 19,476 shares (+inf%) to their portfolio in Q2 2025, for an estimated $25,124
- BLACKROCK, INC. added 18,710 shares (+26.8%) to their portfolio in Q2 2025, for an estimated $24,135
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Vivani Medical Analyst Ratings
Wall Street analysts have issued reports on $VANI in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 09/02/2025
To track analyst ratings and price targets for Vivani Medical, check out Quiver Quantitative's $VANI forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
